Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone in Rett Syndrome
NCT02153723Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Aug 2013
- Primary completion
- Aug 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glatiramer acetate in Rett syndrome (RTT), sponsored by Montefiore Medical Center. Started Aug 2013; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT02153723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153723.